Embed Size (px)
Citation preview
Continued growth and investments within Digital Identity
Interim Report Q2 2020
Published August 14, 2020
Highlights Q2
Net sales growth of 76%
Positive cash flow and EBITDA
Covid-19 pandemic has shown the resilience of our
business model
Continued investments within Digital Identity. Commercial
agreement signed with Temporary Space, collaboration
agreement with NVSS and POCs ongoing with hospitals.
BioMatch Mobile integrated in series of mobile devices
from Samsung and Huawei
2
“It’s about real customer needs, solving problems in today’s digital life”
“Why make it complicated when you can make it simple”
No matter who you arewhere you are and what you do
3
Continued investments within Digital
Identity
4
DIGITAL IDENTITY
4
The market is demanding solutions with the ability to verify a person’s identity in a convenient and secure way
Interest increased due to Covid-19
Increased R&D investments for growth
Successful commercialization and sales activities for facility access –identification for seamless and secure access without the need for keys, cards, tags etc.
PoCs with selected hospitals progressing according to plan
Agreement with Temporary Space for the installment of Precise YOUNiQfor facility access. Precise being a part of their digitalization journey
Focus in sales for growth
5
Further integrations of our fingerprint software in a series of
mobile devices, in collaboration with our partners
Biomatch Mobile integrated in mobile devices from Samsung and Huawei –
two of the largest suppliers of Andriod devices in the world
Focus now is to take a larger share of the software in the value
chain and gain more responsibility in order to strengthen our
position even further
MOBILE
Strenghtening our leading market position
6
The importance of solutions to verify a user's identity to
enable secure contactless payments has been proved
during the pandemic
As customers increasingly demand expediency and
physical distancing - contactless payments becoming a
more preferred method
Generally higher activity but no larger volumes of
biometric payment cards expected from any card
supplier during 2020
Precise product for first generation of biometric cards
completed
Demand for contactless solutions for
payments increases
SMART CARD
6
Financial development
7
Net sales & gross margin
Net sales Q2 MSEK 23.6 (13.4)
Growth by 75.6 %
Gross margin Q2 84.7 % (78.8)
Depreciation of capitalized development
expenses of MSEK 2.3 (2.5)
Gross margin
Net sales
Net sales
8
Operating profit/loss Q2 MSEK -1.1 (-7.3)
EBITDA Q2 MSEK 2.0 (-4.1)
Operating expenses Q2 MSEK 21.1 (17.9)
Increased costs mainly related to investments in
Digital Identity
Higher turnover has led to increased sales
expenses.
EBITDA
Operating profit/loss
Operating profit/loss
Operating profit/loss
9
Cash flow from operating activities Q2 MSEK 2.2 (-1.0)
Cash and cash equivalents per 30/6 MSEK 76,3 (65.4)
Cash and cash equivalents
Cash flow from operating activities
Cash flow from operating activities
Cash flow
10
Covid-19 has shown the resilience of our business model
Continued investments in Digital Identity and important steps taken
within Access
Increased market share in optic sensors for mobile devices – further
integrations of BioMatch Mobile in collaboration with our partners
Generally higher activity within biometric card development but no
larger volumes of biometric payment cards expected from any card
supplier during 2020
Focus for the rest of 2020 is on marketing and sale activities
No matter who you are, where you are and what you do
11
Summary
11
Thank you!
